← Eichor
Condition: Optic Neuropathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Optic Neuropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · 18 location(s) · Jaeb Center for Health Research · NCT06837181
Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
NA · 1 location(s) · NYU Langone Health · NCT06662448
China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3 · 18 location(s) · Dompé Farmaceutici S.p.A · NCT07453888
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1 · 1 location(s) · Tongji Hospital · NCT06620809
Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
NA · 1 location(s) · Steno Diabetes Center Greenland · NCT06264427
Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Phase N/A · 1 location(s) · Tongji Hospital · NCT06885957
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Phase 3 · 33 location(s) · Mayo Clinic · NCT07100990
Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
NA · 1 location(s) · University Hospital, Motol · NCT07149142
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT04106830
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Phase 3 · 11 location(s) · Rhythm Pharmaceuticals, Inc. · NCT06760546
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06780709
Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected
Phase N/A · 9 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT07623252
Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06763848
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
Phase N/A · 3 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT04451265
Hyperbaric Oxygen Therapy for Optic Neuropathies
NA · 1 location(s) · Stanford University · NCT06128720
B-Complex: A Nutraceutical SANS Countermeasure
Phase 1 · 1 location(s) · National Aeronautics and Space Administration (NASA) · NCT05366933
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Phase 2 · 1 location(s) · Qlaris Bio, Inc. · NCT07354477
Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte My
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06865274
New Non-invasive Modalities for Assessing Retinal Structure and Function
NA · 1 location(s) · Randy Kardon · NCT03475173
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NA · 1 location(s) · Medical University of Vienna · NCT03401879
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NA · 1 location(s) · Medical University of Vienna · NCT03870230
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Phase 2/Phase 3 · 51 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT06413654
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
NA · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06124586
Visual Involvement in Giant Cell Arteritis
Phase N/A · 1 location(s) · ASST Fatebenefratelli Sacco · NCT06500728
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
NA · 1 location(s) · Duke University · NCT06841575
Optimize Pediatric OCT Imaging
Phase N/A · 1 location(s) · Duke University · NCT06139523
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.